L-type sarcomas (ie, leiomyosarcoma, liposarcoma) constituted the greatest proportion of cases, and this is indicative by the preponderance of TP53, RB1 alterations and MDM2 and CDK4 amplifications (Table 3). The gene discussed is MDM2; the disease is liposarcoma.